Abacus Life, Inc. (ABL) Q3 2024 Earnings Call Transcript Summary
Abacus Life, Inc. (ABL) Q3 2024 Earnings Call Transcript Summary
Adjusted net income increased by 65% year-over-year to $14.9 million, or $0.20 per diluted share.The following is a summary of the Abacus Life, Inc. (ABL) Q3 2024 Earnings Call Transcript:
以下是愛文思控股(ABL)2024年第三季度業績會議稿摘要：
Financial Performance:
財務表現:
Abacus Life Inc. reported a significant year-over-year revenue growth of 33% to $28.1 million in Q3 2024.
Adjusted EBITDA grew by 54% year-over-year to $16.7 million.
Adjusted net income increased by 65% year-over-year to $14.9 million, or $0.20 per diluted share.
Capital deployed in Q3 was $93.2 million, up from $56.4 million in the prior-year period.
Balance sheet showed cash and equivalents of $19.4 million, policy assets valued at $274.4 million, and long-term debt standing at $166.5 million.
愛文思控股公司報告2024年第三季度營業收入較去年同期增長33%，達到2810萬美元。
調整後的EBITDA較去年同期增長54%，達到1670萬美元。
調整淨利潤較去年同期增長65%，達到1490萬美元，每股稀釋收益爲0.20美元。
第三季度部署的資本爲9320萬美元，高於去年同期的5640萬美元。
資產負債表顯示現金及等價物爲1940萬美元，保單資產價值爲27440萬美元，長期負債爲16650萬美元。
Business Progress:
業務進展:
ABL Tech initiative has seen substantial progress, expecting to exceed one million lives tracked by Q1 2025 through new client acquisitions and outstanding RFP results.
Announced acquisitions of Carlisle Management Company and FCF Advisors, potentially increasing assets under management by $2.6 billion.
Launched PREADISAN in partnership with Lorisco, integrating advanced health prediction technologies into their services.
ABL科技倡議取得了實質性進展，預計通過新客戶收購和出色的RFP成果，在2025年第一季度跟蹤的生命數將超過100萬。
宣佈收購Carlisle Management Company和FCF Advisors，有望將管理資產增加26億美元。
與Lorisco合作推出PREADISAN，將先進的健康預測技術整合到他們的服務中。
Opportunities:
機會：
Anticipate strong growth from the ABL Tech division as it becomes a major contributor to top-line growth.
Acquisitions during the quarter expected to significantly expand asset management capabilities and offerings.
Expansion into health prediction and actuarial tools presents new market opportunities in personalized financial solutions.
預計ABL科技部門的強勁增長將成爲營收增長的重要貢獻者。
本季度的收購預計將顯著擴大資產管理能力和業務範圍。
進軍健康預測和精算工具領域爲個性化金融解決方案帶來新的市場機遇。
Risks:
風險：
Key risks include the realization of business acquisitions and integration risks associated with Carlisle Management Company and FCF Advisors.
主要風險包括實現對卡萊爾管理公司和FCF顧問的業務收購和整合風險。
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：如需更全面的詳情，請參閱投資人關係網站。本文僅供投資者參考，不作任何指引或建議。
譯文內容由第三人軟體翻譯。
